Business
Appointment of Strategic Advisor
Appointment of Strategic Advisor.
About this update from Chill Brands Group Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 5148N\n Chill Brands Group PLC\n 30 September 2021\n \n \n \n \n \n \n \n \n For immediate release\n \n \n \n \n 30 September 2021\n \n \n \n \n \n \n \n \n \n THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310\n \n \n \n \n \n Chill Brands Group PLC\n \n \n ('Chill', the 'Company' or the 'Group')\n \n \n \n \n Appointment of Strategic Advisor\n \n \n Chill Brands Group plc (LON:CHLL) (OTCQX:ZOEIF), the international CBD group, is pleased to announce the appointment of Viridian Capital Advisors as a strategic advisor in connection with capital raising strategy, M&A strategy, development of its board of directors and investor relations.\n \n \n \n \n Highlights\n \n \n \n \n · \n In June 2014, Viridian Capital Advisors (\"Viridian\" or \"VCA\") was founded as one of the first financial and strategic advisory firms in the US cannabis/hemp industry, with a team of seasoned advisors, investment bankers and analysts.\n \n \n \n \n \n · \n Viridian's Board of Advisors is comprised of senior executives from some of the largest brand companies in the world, including Diageo, Proctor & Gamble, Anheuser Busch, Mars Wrigley and Philip Morris.\n \n \n \n \n \n · \n VCA has been engaged by some of the best of breed emerging growth companies in the US cannabis/hemp industry.\n \n \n \n \n \n · \n Viridian is widely quoted by the mainstream media as an expert in the cannabis/hemp industry, including Reuters, CNN, Forbes, Bloomberg, and the Wall Street Journal.\n \n \n \n \n \n · \n Viridian's President, Scott Greiper, will address shareholders during the Company's Annual General Meeting that is being held later today.\n \n \n \n \n \n Chill's advisory agreement with Viridian is focused on building the business, profile, market value and liquidity of the Company.\n \n \n \n \n \n As part of the agreement, Viridian has today been issued warrants exercisable into 4.9% of the Company's fully diluted ordinary share capital (representing approximately 11,290,826 ordinary shares), with an exercise period of five years and an exercise price of 1 pence per ordinary share of 1 pence each (\"Ordinary ...